more generic ARBs in 2012

You'll see more generic ARBs in 2012...irbesartan (Avapro) in March...valsartan (Diovan) in Sept...and candesartan (Atacand) in Dec.

But this DOESN'T mean ARBs should be used first-line instead of ACE inhibitors. ACEIs still have more evidence for improving outcomes.

Continue to suggest saving ARBs for patients who can't take an ACEI.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote